We shown that, in contrast to classical opioid receptors, ACKR3 won't result in classical G protein signaling and is not modulated with the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists for instance naloxone. Instead, we established that LIH383, an ACKR3-selective subnanomolar https://erasmusa066gei0.liberty-blog.com/profile